← Back to Clinical Trials
Recruiting NCT06478823

NCT06478823 Healthy Stool Volunteer Donors for Fecal Microbiota Transplantation Trials

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06478823
Status Recruiting
Phase
Sponsor Assistance Publique - Hôpitaux de Paris
Condition Gastro-Intestinal Disorder
Study Type INTERVENTIONAL
Enrollment 400 participants
Start Date 2024-07-08
Primary Completion 2030-05

Trial Parameters

Condition Gastro-Intestinal Disorder
Sponsor Assistance Publique - Hôpitaux de Paris
Study Type INTERVENTIONAL
Phase N/A
Enrollment 400
Sex ALL
Min Age 18 Years
Max Age 49 Years
Start Date 2024-07-08
Completion 2030-05
Interventions
Stools donation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Currently, ANSM recommendations govern FMT (Fecal Microbiota Transplantation) in clinical trials. The collection and validation of these stool donations as part of the trials is complex and not very efficient. It therefore seems essential to identify the limiting factors and the characteristics of Healthy Volunteer Donors to optimize the number of valid stool donations.

Eligibility Criteria

Inclusion Criteria: \- Age ≥ 18 years and \< 50 years * 17 kg/m² \< body mass index \< 30 kg/m² * Regular bowel movement defined as at least 1 stool every other day and maximum 2 stools per day * Subject with health insurance (AME excepted) * Informed written consent Exclusion Criteria: Definitive non-inclusion criteria: 1. Infectious risk : \- Known HIV, HBV, HCV, HTLV infection \- Residence of more than 2 years in the intertropics zone within the previous 5 years \- Hospitalization abroad for more than 24 hours in the last 12 months (including a member of the healthy volunteers donor's entourage) \- Risk factors for Creutzfeldt-Jakob disease (history: treatment with extractive growth hormone, a family case of transmissible spongiform subacute encephalopathy, surgery with opening of the dura or neurosurgery or invasive brain exploration before 1 January 1995, stay in United Kingdom for a duration greater than 1 year cumulatively between 1980 and 1996 or the presence of neurological or

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology